Table 2.

Sociodemographic and disease-related outcomes stratified by consumption group.

Total	Non-polytox	Adult	Preadult	p
Mean (SD)
Age (years)
39.59 (12.71)	41.98 (12.73)	34.00 (9.81)	28.86 (6.86)	6.26e−62
n = 1559	n = 1192	n = 213	n = 154
Age at disease onset (years)
25.95 (8.81)	27.21 (9.22)	22.60 (6.17)	20.82 (4.66)	5.87e−38
n = 1531	n = 1170	n = 210	n = 151
Chlorpromazine equivalents
679.25 (670.09)	669.81 (678.96)	740.58 (694.05)	669.71 (558.51)	0.38
n = 1513	n = 1161	n = 202	n = 150
Premorbid intelligence MWT-B-corrected
0.04 (1.00)	0.05 (1.04)	0.13 (0.96)	−0.16 (0.70)	0.002
n = 1440	n = 1101	n = 194	n = 145

MWT-B Mehrfachwahl–Wortschatz–Intelligenztest-B; Premobid intelligence: Standardized residuals corrected for Chlorpromazine equivalents and age. Sample sizes vary because of missing data. Bold values indicate significant differences between means of the three consumption groups. Underlined p values remain significant after Bonferroni correction (p < 0.05/4 = 0.0125). Two-sided Welch’s ANOVA (age, age at disease onset, premorbid intelligence) or ANOVA (Chlorpromazine equivalents) applied.